Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04869345 · ClinicalTrials.gov registry record · NA
Positive Affect as a Source of Resilience for Adults in Chronic Pain
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT04869345 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 95 participants.
The verdict
NCT04869345, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
Fibromyalgia syndrome (FMS) is a chronic musculoskeletal condition characterized by widespread pain and tenderness, and often accompanied by impaired physical functioning, depressed mood, as well as deficits in positive affect (PA).Standard behavioral therapies typically focus on minimizing negative thoughts and emotions associated with pain and yield only modest treatment effects. Efforts are therefore needed to develop more effective psychological treatments for chronic pain by identifying new targets for intervention. The objectives of this Stage I randomized pilot trial are to evaluate the feasibility, acceptability, and the impact of a previously developed online positive affect (PA) skills intervention -LARKSPUR (Lessons in Affect Regulation to Keep Stress and Pain UndeR control)-in a sample of Hispanic, non-Hispanic other, and non-Hispanic African American patients with fibromyalgia syndrome (FMS).
Interventions
- BEHAVIORAL LARKSPUR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2022-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04869345
The ClinicalTrials.gov registry entry for NCT04869345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LARKSPUR is the first listed.
NCT04869345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04869345 about?
NCT04869345 is a clinical study titled "Positive Affect as a Source of Resilience for Adults in Chronic Pain". Fibromyalgia syndrome (FMS) is a chronic musculoskeletal condition characterized by widespread pain and tenderness, and often accompanied by impaired physical functioning, depressed mood, as well as deficits in positive affect (PA).Standard behavioral therapies typically focus on minimizing negative...
What is the current status of trial NCT04869345?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2021-07-27. Estimated completion is 2022-06-09.
What interventions are being tested in trial NCT04869345?
The interventions under investigation include: LARKSPUR (BEHAVIORAL).
Who is sponsoring clinical trial NCT04869345?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.